LMAT Q2 2024 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$56M+11.4% YoY

Gross Profit

$38M68.9% margin

Operating Income

$14M25.7% margin

Net Income

$12M21.2% margin

EPS (Diluted)

$0.52

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$363M

Total Liabilities

$44M

Stockholders' Equity

$320M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$50M	+11.4%
Gross Profit	$38M	$32M	+19.9%
Operating Income	$14M	$9M	+52.1%
Net Income	$12M	$8M	+46.0%

Geographic Segments

Americas

$37M66%

EMEA

$15M27%

Asia Pacific

$4M7%